HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Su-Hyung Park Selected Research

Member 9 Tumor Necrosis Factor Receptor Superfamily

12/20204-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39+ CD8 T cells from primary and metastatic sites of epithelial ovarian cancers.
1/20204-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Su-Hyung Park Research Topics

Disease

23Infections
01/2022 - 11/2003
16Neoplasms (Cancer)
01/2022 - 12/2018
6COVID-19
10/2022 - 10/2020
4Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2017
4Virus Diseases (Viral Diseases)
01/2020 - 12/2005
4Chronic Hepatitis C
01/2020 - 07/2008
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2019
3Inflammation (Inflammations)
01/2018 - 01/2016
2Liver Diseases (Liver Disease)
10/2022 - 11/2003
2Disease Progression
01/2021 - 11/2020
2Multiple Myeloma
01/2021 - 01/2020
2Human Influenza (Influenza)
10/2020 - 09/2005
2Retinoblastoma (Glioblastoma, Retinal)
01/2019 - 11/2017
2Melanoma (Melanoma, Malignant)
01/2019 - 01/2018
2Severe Fever with Thrombocytopenia Syndrome
01/2019 - 11/2017
2Glioblastoma (Glioblastoma Multiforme)
01/2019 - 01/2019
2Pneumonia (Pneumonitis)
01/2018 - 01/2017
2Hepatitis A (Hepatitis, Infectious)
01/2018 - 01/2017
2Viremia
08/2014 - 10/2012
1Fatigue
03/2022
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2022
1Necrosis
01/2022
1Abdominal Aortic Aneurysm
04/2021
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2021
1Ovarian Neoplasms (Ovarian Cancer)
12/2020
1Pemphigus (Pemphigus Vulgaris)
11/2020
1Autoimmune Diseases (Autoimmune Disease)
11/2020
1Reinfection
01/2020
1Nasal Polyps (Nasal Polyp)
01/2020
1Rhinosinusitis
01/2020
1Fibrosis (Cirrhosis)
01/2020
1Asthma (Bronchial Asthma)
01/2020
1Colorectal Neoplasms (Colorectal Cancer)
11/2019
1Neoplasm Metastasis (Metastasis)
01/2019
1Colonic Neoplasms (Colon Cancer)
01/2019
1Chronic Hepatitis B
01/2019
1Herpes Zoster
10/2018
1Hypertension (High Blood Pressure)
01/2018
1Coronavirus Infections
01/2018

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
03/2022 - 12/2010
9CytokinesIBA
01/2022 - 01/2018
8VaccinesIBA
03/2022 - 11/2003
7RNA (Ribonucleic Acid)IBA
01/2022 - 12/2013
5DNA VaccinesIBA
03/2022 - 09/2005
5Immune Checkpoint InhibitorsIBA
02/2020 - 12/2018
4DNA (Deoxyribonucleic Acid)IBA
03/2022 - 07/2008
4InterferonsIBA
01/2022 - 12/2011
4Programmed Cell Death 1 ReceptorIBA
01/2021 - 01/2019
4Antiviral Agents (Antivirals)IBA
11/2020 - 01/2019
3Interferon Type IIBA
10/2022 - 10/2020
3Interleukin-15 (Interleukin 15)IBA
01/2022 - 01/2021
3AntigensIBA
01/2019 - 01/2018
3Messenger RNA (mRNA)IBA
01/2019 - 01/2017
3ChemokinesIBA
01/2018 - 08/2011
2InterleukinsIBA
01/2022 - 01/2021
2Interleukin-17 (Interleukin 17)IBA
04/2021 - 01/2016
2NivolumabIBA
01/2021 - 01/2019
2Member 9 Tumor Necrosis Factor Receptor SuperfamilyIBA
12/2020 - 01/2020
2Interleukin-33IBA
11/2020 - 10/2018
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2020 - 01/2020
2AntibodiesIBA
01/2020 - 12/2013
2A-Form DNA (A-DNA)IBA
01/2020 - 11/2017
2Interleukin-7 (Interleukin 7)IBA
10/2018 - 12/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 10/2012
2Interleukin-6 (Interleukin 6)IBA
01/2018 - 01/2017
2LigandsIBA
01/2016 - 04/2013
2Ribavirin (Virazole)FDA LinkGeneric
01/2014 - 07/2008
1GX-19N vaccineIBA
03/2022
1SARS-CoV-2 spike proteinIBA
03/2022
1Nucleocapsid ProteinsIBA
03/2022
1mRNA VaccinesIBA
01/2022
1BNT162 VaccineIBA
01/2022
1Neutralizing AntibodiesIBA
01/2022
1Granzymes (Granzyme)IBA
01/2022
1Biological ProductsIBA
01/2022
1daratumumabIBA
01/2021
1regorafenibIBA
01/2021
1B7-H1 AntigenIBA
01/2021
1Immune Checkpoint ProteinsIBA
11/2020
1Chemokine ReceptorsIBA
11/2020
1Inducible T-Cell Co-Stimulator ProteinIBA
11/2020
1Blocking AntibodiesIBA
11/2020
1AutoantibodiesIBA
11/2020
1Desmoglein 3IBA
11/2020
1Enterotoxins (Enterotoxin)IBA
01/2020
1SuperantigensIBA
01/2020
1Immunoglobulin E (IgE)IBA
01/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2019
1pembrolizumabIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1Temozolomide (Temodar)FDA LinkGeneric
01/2019
1ResveratrolIBA
01/2019
1HLA-A*02:01 antigenIBA
12/2018
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2018
1AlbuminsIBA
01/2018
1MART-1 AntigenIBA
01/2018

Therapy/Procedure

9Therapeutics
12/2020 - 07/2008
7Immunotherapy
01/2022 - 07/2019
3Liver Transplantation
10/2022 - 01/2020
1Aftercare (After-Treatment)
01/2019